FDA moves on superbugs, Pfizer’s R&D shrinks and no one is ready if Obamacare crumbles (Morning Read)
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content. TOP STORIES Fast action on superbugs from the FDA. The U.S. Food and Drug Administration […]